Nicholas J Hess

8PUBLICATIONS
17CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 12, 2024
TLR10 (CD290) Is a Regulator of Immune Responses in Human Plasmacytoid Dendritic Cells.

Pratik Deb, Sukhwinder Singh, Evelyne Kalyoussef

|Jun 19, 2023
Combination fedratinib and venetoclax has activity against human B-ALL with high FLT3 expression.

Sean P Rinella, Haley C Bell, Nicholas J Hess

|Mar 24, 2023
Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology.

Nicholas J Hess, David P Turicek, Jeremiah Riendeau

|Jun 11, 2021
iNKT cells coordinate immune pathways to enable engraftment in nonconditioned hosts.

Nicholas J Hess, Nikhila S Bharadwaj, Elizabeth A Bobeck

|Apr 12, 2021
CXCR4 allows T cell acute lymphoblastic leukemia to escape from JAK1/2 and BCL2 inhibition through CNS infiltration.

Kirsti L Walker, Sean P Rinella, Nicholas J Hess

|May 24, 2020
Early T Cell Activation Metrics Predict Graft-versus-Host Disease in a Humanized Mouse Model of Hematopoietic Stem Cell Transplantation.

Nicholas J Hess, Amy W Hudson, Peiman Hematti

Pageof 2

Frequent Collaborators

3 joint publications

Amy W Hudson

3 joint publications

Jenny E Gumperz

3 joint publications

Christian M Capitini

2 joint publications

Peiman Hematti